Advertisement

Topics

Cell Therapies Pty Ltd Company Profile

13:15 EST 14th December 2018 | BioPortfolio

Cell Therapies Pty Ltd is in the business of planning and conducting clinical trials that involve the collection, manipulation and storage of blood cells and human tissue. The services range from laboratory rental through to fully-integrated planning and execution of clinical trials that involve cellular therapeutics manufactured in code of Good Manufacturing Practice (cGMP) and Therapeutic Goods Administration (TGA) licensed facilities.

Location

105 Highgrove Drive
Chapel Hill
North Carolina
United States of America

Contact

Phone: (919) 969 1130
Email: Miles.Prince@petermac.org


News Articles [1761 Associated News Articles listed on BioPortfolio]

CAR T-Cell Therapies Moving to Outpatient Setting

The high durable response rates seen with CAR T-cell therapies have helped fill a high unmet need for patients with relapsed/refractory diffuse large B-cell lymphoma, with questions remaining on the o...

CAR T-Cell Therapies Show Durable Responses, New Research Also Explores Combination Therapies ...

SAN DIEGO, Dec. 3, 2018 /PRNewswire/ -- Chimeric antigen receptor (CAR) T-cell therapies have quickly shifted the treatment paradigm for many people with several types Read more...

Stem Cell Therapies in Neurology

NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Stem Cell Therapies in Neurology Summary "Stem Cell Therapies in Neurology", is an evolving field. The current pipeline Read more...

US FDA Recommends Use Of Pre-Built Facilities To Ease Scale-Up Process For Cell And Gene Therapies

As applications for expedited review of cell and gene therapies soar, it is important for their sponsors to take certain...   

Gene and cell therapies: making manufacturing work

Gene and cell therapies are two of the fastest emerging areas of medicine. Comprising techniques such as gene editing and...Read More... The post Gene and cell therapies: making manufacturing work app...

PhRMA Highlights Impact of Cell and Gene Therapies in New Report

This morning the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that shows there are nearly 300 novel cell and gene therapies currently in development throughout the in...

ASH 2018: CAR T-Cell therapies show durable responses, new research also explores combination therapies to extend and enhance treatment responses

Chimeric antigen receptor (CAR) T-cell therapies have quickly shifted the treatment paradigm for many people with several types of aggressive blood cancers, in whom treatment options have been woefull...

AbbVie and Calibr partner to develop T-cell therapies for cancer

AbbVie has formed an alliance with Scripps Research’s non-profit drug discovery unit Calibr to develop next-generation T-cell therapies that are...Read More... The post AbbVie and Calibr partner to ...

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Cladribine [Onco Therapies Limited ]

Cladribine Injection

Zolinza [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use ZOLINZA safely and effectively. See full prescribing information for ZOLINZA. ZOLINZA® (vorinostat) CapsulesInitial U.S. Approval: 20...

Humira [Abbott Laboratories]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA.HUMIRA (adalimumab) Injection, Solution for Subcutaneous us...

Sun care [Zenith Medicosm SL]

Drug Facts

Sun care [Zenith Medicosm SL]

Drug Facts

PubMed Articles [3614 Associated PubMed Articles listed on BioPortfolio]

CAR T-cell Therapy for Solid Tumors?

Scientists have identified a wide variety of challenges preventing the development of effective CAR T-cell therapies for solid tumors, but they are investigating just as many potential solutions. Prog...

Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies.

Continuing Challenges in Advancing Preclinical Science in Skeletal Cell-Based Therapies and Tissue Regeneration.

Cell-based therapies hold much promise for musculoskeletal medicine; however, this rapidly growing field faces a number of challenges. Few of these therapies have proven clinical benefit, and an insuf...

Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report.

Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, cli...

With Probiotics, Resistance Is Not Always Futile.

Probiotics and other bacteriotherapies are actively being explored and applied as symptom- and disease-modifying agents. In a recent issue of Cell, two papers contribute to our understanding of how li...

Clinical Trials [8148 Associated Clinical Trials listed on BioPortfolio]

Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

Cell-based therapies in the form of stem cell-based or immune cell-based therapies are becoming important treatment options that are either approved for clinical use or are showing promise...

Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer

Gene and cell therapies have a real value potential (example: potential long-term effect, curative potential, and single administration) but also drawbacks (example: treatment perceived as...

Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer

This will be a single arm, multi-site phase Ib/II clinical trial of standard doses of High Dose Interleukin-2 (HD IL2) (600,000 IU/kg/dose intravenously during two 5-day cycles 9 days apar...

Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma

The purpose of this study is to validate of a predictive nomogram of response or resistance to targeted therapies in metastatic clear cell renal cell carcinoma

Treatment of Chronic Lymphocytic Leukemia

CLL is a disease of the elderly, identifying effective therapies with better toxicity profiles is thus a high priority, and targeted therapies may allow attainment of this goal.

Companies [1781 Associated Companies listed on BioPortfolio]

Beike Biotechnology Company Limited

Beike Biotechnology (http://www.beikebiotech.com) is Asia's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and commerc...

Beike Biotechnology Co. Ltd.

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company focusing on adult stem cell therapies. Beike's scientists have been focused on the development and comme...

Triumvira Immunologics Inc.

Triumvira Immunologics, Inc. is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., a niche life-sciences investment...

Triumvira Immunologics, Inc.

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the...

Autolus Therapeutics Limited

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and m...

More Information about "Cell Therapies Pty Ltd" on BioPortfolio

We have published hundreds of Cell Therapies Pty Ltd news stories on BioPortfolio along with dozens of Cell Therapies Pty Ltd Clinical Trials and PubMed Articles about Cell Therapies Pty Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Therapies Pty Ltd Companies in our database. You can also find out about relevant Cell Therapies Pty Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record